Interestingly the valuation jumps 50% from Phase3 to FDA approval.
While NEU has a market value well below the average values listed, putting that aside I think the potential increase in value after FDA approval could see the price around $6.
NEU’s performance after the successful Phase 3 result of an increase in price of a bit over 100% seems to be in line with the data mentioned.
Here’s hoping.
Best position ever ., page-38
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.18 |
Change
-0.430(3.16%) |
Mkt cap ! $1.684B | |||
| Open | High | Low | Value | Volume |
| $13.64 | $13.67 | $13.18 | $8.868M | 666.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 5233 | $13.18 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.24 | 1000 | 1 |
View Market Depth
| Last trade - 16.10pm 09/10/2024 (20 minute delay) ? |
| NEU (ASX) Chart |